Abstract
Purpose: To determine the effects of L-carnitine on sperm parameters in patients with idiopathic sperm abnormalities.
Methods: In an academic reproductive care center, 170 patients including 48 smokers and 122 non-smokers participated in a before–after study. Men were given 1 g of L-carnitine orally 3 × daily for 3 months. Sperm assessment was done before and after the treatment. Main outcome measures were sperm concentration, motility, and morphology before and after the treatment.
Results:L-Carnitine was effective in improvement of percentile of motile sperms, grade A sperms, and normal-shaped sperms. L-Carnitine significantly improved percentile of motile and grade A sperms in non-smokers. Only the change in the median percentile of normal forms was within the significant range in smokers.
Conclusions: The results of this study indicate that smoker patients should not be excluded from the treatment with L-carnitine based on smoking alone.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Whitman-Elia GF, Baxley EG: A primary care approach to the infertile couple. J Am Board Fam Pract 2001;14:33–45
de Kretser DM: Male infertility. Lancet 1997;349:787–790
Costa M, Canale D, Filicori M, D'Iddio S, Lenzi A: L-Carnitine in idiopathic asthenozoospermia: A multicenter study. Italian Study Group on Carnitine and Male infertility. Andrologia 1994;26:155–159
Lenzi A, Lombardo F, Sgro P, Salacone P, Caponecchia L, Dondero F, Gandini L: Use of carnitine therapy in selected cases of male factor infertility: A double-blind crossover trial. Fertil Steril 2003;79:292–300
Vicari E, Calogero AE: Effects of treatment with carnitines in infertile patients with prostato-vesiculo-epididymitis. Hum Reprod 2001;16:2338–2342
Brooks DE: Carnitine in the male reproductive tract and its relation to the metabolism of the epididymis and spermatozoa. In Carnitine biosynthesis, Metabolism and Functions, RA Frenkel, D McGarry (eds), New York, Academic Press, 1980; pp. 219–235
Vitali G, Parente R, Melotti C: Carnitine supplementation in human idiopathic asthenospermia: Clinical results. Drug Exp Clin Res 1995;21:157–159
Moncada ML, Vicari E, Cimino C, Calogero AE, Mongioi A, D'Agata R: Effect of acetylcarnitine treatment in oligoasthenospermic patients. Acta Eur Fertil 1992;23:221–224
Lewin LM, Beer R, Lunenfeld B: Epididymis and seminal vesicle as sources of carnitine in human seminal fluid: The clinical significance of the carnitine concentration in human seminal fluid. Fertil Steril 1976;27:9–13
Campaniello E, Petrarolo N, Meriggiola MC, et al.: Carnitine administration in asthenospermia. IV International Congress of Andrology, Firenze, May 14–18, 1989
Verajankorva E, Laato M, Pollanen P: Analysis of 508 infertile male patients in south-western Finland in 1980–2000: Hormonal status and factors predisposing to immunological infertility. Eur J Obstet Gynecol Reprod Biol 2003;111:173–178
Marinelli D, Gaspari L, Pedotti P, Taioli E: Mini-review of studies on the effect of smoking and drinking habits on semen parameters. Int J Hyg Environ Health 2004;207:185–192
Centers for Disease Control and Prevention (CDC): State-specific prevalence of current cigarette smoking among adults—United States, 2003. MMWR Morb Mortal Wkly Rep 2004;53:1035–1037
Wroblewski N, Schill WB, Henkel R: Metal chelators change the human sperm motility pattern. Fertil Steril 2003;79 (suppl 3):1584–1589
Zitzmann M, Rolf C, Nordhoff V, Schrader G, Rickert-Fohring M, Gassner P, Behre HM, Greb RR, Kiesel L, Nieschlag E: Male smokers have a decreased success rate for in vitro fertilization and intracytoplasmic sperm injection. Fertil Steril 2003;79(suppl 3):1550–1554
World Health Organization: WHO Laboratory manual for examination of human semen and sperm-cervical mucus interaction, 4th ed. Cambridge, Cambridge University Press, 1999
Kruger TF, Menkveld R, Stander FS, Lombard CJ, Van Der Merwe JP, Van Zyl JA, Smith K: Sperm morphologic features as a prognostic factor in in vitro fertilization. Fertil Steril 1986;46:1118–1123
Deana R, Indino M, Rigoni F, Foresta C: Effect of L-carnitine on motility and acrosome reaction of human spermatozoa. Arch Androl 1988;21:147–153
Vine MF, Tse CK, Hu P, Truong KY: Cigarette smoking and semen quality. Fertil Steril 1996;65:835–842
Wang SL, Wang XR, Chia SE, Shen HM, Song L, Xing HX, Chen HY, Ong CN: A study on occupational exposure to petrochemicals and smoking on seminal quality. J Androl 2001;22:73–78
Wong WY, Thomas CM, Merkus HM, Zielhuis GA, Doesburg WH, Steegers-Theunissen RP: Cigarette smoking and the risk of male factor subfertility: Minor association between cotinine in seminal plasma and semen morphology. Fertil Steril 2000;74:930–935
Zavos PM, Correa JR, Antypas S, Zarmakoupis-Zavos PN, Zarmakoupis CN: Effects of seminal plasma from cigarette smokers on sperm viability and longevity. Fertil Steril 1998;69:425–429
Khademi A, Safdarian L, Alleyassin A, Agha-Hosseini M, Akbari Hamed E, Saeidi Saeidabadi H, Pooyan O: The effect of L-carnitine on sperm parameters in patients candidated for intracytoplasmic sperm injection. Iranian J Reprod Med 2004;2:65–69
Micic S: Effects of L-carnitine on sperm motility and number in infertile men. Fertil Steril 1998;70(suppl 1):S383
www.cdc.gov/nceh/dls/tobacco.htm
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Khademi, A., Alleyassin, A., Safdarian, L. et al. The effects of L-carnitine on sperm parameters in smoker and non-smoker patients with idiopathic sperm abnormalities. J Assist Reprod Genet 22, 395–399 (2005). https://doi.org/10.1007/s10815-005-7204-4
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10815-005-7204-4